297 related articles for article (PubMed ID: 26850689)
1. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells.
Bassa LM; Jacobs C; Gregory K; Henchey E; Ser-Dolansky J; Schneider SS
Phytomedicine; 2016 Jan; 23(1):87-94. PubMed ID: 26850689
[TBL] [Abstract][Full Text] [Related]
2. Rhodiola crenulata inhibits Wnt/β-catenin signaling in glioblastoma.
Mora MC; Bassa LM; Wong KE; Tirabassi MV; Arenas RB; Schneider SS
J Surg Res; 2015 Aug; 197(2):247-55. PubMed ID: 25998182
[TBL] [Abstract][Full Text] [Related]
3. Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines.
Tu Y; Roberts L; Shetty K; Schneider SS
J Med Food; 2008 Sep; 11(3):413-23. PubMed ID: 18800886
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line.
Wong KE; Mora MC; Sultana N; Moriarty KP; Arenas RB; Yadava N; Schneider SS; Tirabassi MV
Tumour Biol; 2018 Jun; 40(6):1010428318779515. PubMed ID: 29871587
[TBL] [Abstract][Full Text] [Related]
6. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activities of extracts of Chinese licorice (Glycyrrhiza uralensis) root in MCF-7 breast cancer cells.
Hu C; Liu H; Du J; Mo B; Qi H; Wang X; Ye S; Li Z
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):209-16. PubMed ID: 19167497
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic activity in white and red wine extracts.
Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.
Dudek MC; Wong KE; Bassa LM; Mora MC; Ser-Dolansky J; Henneberry JM; Crisi GM; Arenas RB; Schneider SS
Tumour Biol; 2015 Dec; 36(12):9795-805. PubMed ID: 26159852
[TBL] [Abstract][Full Text] [Related]
10. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells.
Gregory KJ; Schneider SS
Cell Biol Int; 2015 Jul; 39(7):873-9. PubMed ID: 25809273
[TBL] [Abstract][Full Text] [Related]
12. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Estrogenic and Breast Cancer Inhibitory Activities of Chemical Constituents Isolated from Rheum undulatum L.
Lee D; Park S; Choi S; Kim SH; Kang KS
Molecules; 2018 May; 23(5):. PubMed ID: 29783719
[TBL] [Abstract][Full Text] [Related]
14. Rhodiola crenulata extract suppresses hepatic gluconeogenesis via activation of the AMPK pathway.
Lee SY; Lai FY; Shi LS; Chou YC; Yen IC; Chang TC
Phytomedicine; 2015 Apr; 22(4):477-86. PubMed ID: 25925970
[TBL] [Abstract][Full Text] [Related]
15. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
16. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
[TBL] [Abstract][Full Text] [Related]
19. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor subtypes dictate the proliferative nature of the mammary gland.
Dall GV; Hawthorne S; Seyed-Razavi Y; Vieusseux J; Wu W; Gustafsson JA; Byrne D; Murphy L; Risbridger GP; Britt KL
J Endocrinol; 2018 Jun; 237(3):323-336. PubMed ID: 29636363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
